You are here

Palatka Károly

Palatka Károly

Palatka Károly
Name: Palatka Károly
Other profiles: MTMT
Profession: physician, gastroenterologist

Publication list

Uploaded publications:
88
Publications in DEA:
87
OA:
19
Date range:
1995-2023
2023
  1. Palatka, R., Janka, E., Soltész, L., Szabó, I., Kapitány, A., Dajnoki, Z., Emri, G., Nagy, G., Palatka, K., Zouboulis, C., Szegedi, A., Gáspár, K.: Chronic inflammatory intestinal disorders in hidradenitis suppurativa.
    Dermatology. 239 (4), 592-600, 2023.
    Journal metrics:
    Q1 Dermatology (2022)
2022
2021
  1. Szántó, K., Mezei, Z., Kata, D., Földesi, I., Nyári, T., Fábián, A., Rutka, M., Bor, R., Bálint, A., Milassin, Á., Szepes, Z., Nagy, F., Palatka, K., Farkas, K., Molnár, T.: Combination therapy with anti-TNFs and thiopurines does affect drug metabolite levels but it is not associated with body composition in inflammatory bowel disease patients: a cross-sectional study.
    Gasztroenterol. Hepatol. Szle. 7 (4), 164-170, 2021.
2020
  1. Bor, R., Fábián, A., Matuz, M., Szepes, Z., Farkas, K., Miheller, P., Szamosi, T., Vincze, Á., Rutka, M., Szántó, K., Bálint, A., Nagy, F., Milassin, Á., Tóth, T., Zsigmond, F., Bajor, J., Müllner, K., Lakner, L., Papp, M., Salamon, Á., Horváth, G., Sarang, K., Schafer, E., Sarlós, P., Palatka, K., Molnár, T.: Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease: a nationwide Hungarian cohort study.
    Expert Opin. Biol. Ther. 20 (2), 205-213, 2020.
    Journal metrics:
    Q1 Clinical Biochemistry
    Q1 Drug Discovery
    Q1 Pharmacology
2019
  1. Szántó, K., Szíjártó, A., Kata, D., Földesi, I., Mezei, Z., Fábián, Á., Bálint, A., Bor, R., Farkas, K., Milassin, Á., Rutka, M., Szepes, Z., Nagy, F., Bubán, T., Lovas, S., Palatka, K., Molnár, T.: Blood thiopurine level, anti-TNF drug level and body composition parameters in inflammatory bowel diseases patients: a cross-sectional study in a Hungarian IBD centre.
    J. Crohns Colitis. 13 (Supplement1), S456, 2019.
  2. Kucserik, L., Márta, K., Vincze, Á., Lázár, G., Czakó, L., Szentkereszty, Z., Papp, M., Palatka, K., Izbéki, F., Altorjay, Á., Török, I., Barbu, S., Tantau, M., Vereczkei, A., Bogár, L., Dénes, M., Németh, I., Szentesi, A., Zádori, N., Antal, J., Lerch, M., Neoptoleomos, J., Sahin-Tóth, M., Petersen, O., Kelemen, D., Hegyi, P.: Endoscopic sphincterotoMy for delayIng choLecystectomy in mild acute biliarY pancreatitis (EMILY study): protocol of a multicenter randomized clinical trial.
    BMJ Open. 9 (7), 1-8, 2019.
    Journal metrics:
    Q1 Medicine (miscellaneous)
  3. Milassin, Á., Rutka, M., Farkas, K., Bálint, A., Bor, R., Fábián, A., Szepes, Z., Szamosi, T., Szántó, K., Miheller, P., Barta, Z., Banai, J., Kovács, Á., Salamon, Á., Lakatos, L., Lakner, L., Palatka, K., Papp, M., Schafer, E., Novák, J., Erdélyi, Z., Kürti, Z., Lakatos, P., Sarlós, P., Szigeti, N., Veres, G., Zaránd, A., Gelley, A., Vincze, Á., Nagy, F., Molnár, T.: IBD-related malignancies observed in 2015-2018: 4 years' results from the prospective nationwide Hungarian registry.
    J. Crohns Colitis. 13 (Suppl.), S380-S381, 2019.
  4. Rencz, F., Stalmeier, P., Péntek, M., Brodszky, V., Rúzsa, G., Gönczi, L., Palatka, K., Herszényi, L., Schafer, E., Banai, J., Rutka, M., Gulácsi, L., Lakatos, P.: Patient and general population values for luminal and perianal fistulising Crohn's disease health states.
    Eur. J. Health Econ. 20 (Suppl1), 91-100, 2019.
    Journal metrics:
    D1 Economics, Econometrics and Finance (miscellaneous)
    Q1 Health Policy
2018
  1. Molnár, T., Nagy, F., Fritz, P., Lakatos, L., Erdélyi, Z., Miheller, P., Szamosi, T., Schafer, E., Vincze, A., Sarlós, P., Banai, J., Kovács, A., Novák, J., Salamon, A., Szepes, A., Szigeti, N., Juhász, M., Müllner, K., Barta, Z., Kadenczki, O., Gelley, A., Palatka, K., Papp, M., Zaránd, A., Lakatos, P., Veres, G., Rutka, M., Bálint, Á., Bor, R., Milassin, Á., Fábián, A., Szepes, Z., Farkas, K.: IBD-related malignancies and mortalities observed in 2015-2017: 3 years' results from the prospective nationwide Hungarian registry.
    J. Crohns Colitis. 12 (Suppl.), S540-S541, 2018.
  2. Bálint, A., Rutka, M., Kolar, M., Bortlik, M., Duricova, D., Hruba, V., Lukas, M., Mitrova, K., Malickova, K., Lukas, M., Szepes, Z., Nagy, F., Palatka, K., Lovas, S., Végh, Z., Kürti, Z., Csontos, Á., Miheller, P., Nyári, T., Bor, R., Milassin, Á., Fábián, A., Szántó, K., Lakatos, P., Molnár, T., Farkas, K.: Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis: results from multicenter observational cohort.
    Expert Opin. Biol. Ther. 18 (11), 1181-1187, 2018.
    Journal metrics:
    Q1 Clinical Biochemistry
    Q1 Drug Discovery
    Q1 Pharmacology
  3. Rencz, F., Lakatos, P., Gulácsi, L., Brodszky, V., Kürti, Z., Lovas, S., Banai, J., Herszényi, L., Cserni, T., Molnár, T., Péntek, M., Palatka, K.: Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.
    Qual. Life Res. 28 (1), 141-152, 2018.
    Journal metrics:
    Q1 Public Health, Environmental and Occupational Health
2017
  1. Molnár, T., Rutka, M., Nagy, F., Fritz, P., Lakatos, L., Miheller, P., Erdélyi, Z., Szamosi, T., Schafer, E., Vincze, A., Sarlós, P., Banai, J., Kovács, Á., Novák, J., Salamon, A., Szepes, A., Szigeti, N., Juhász, M., Müllner, K., Barta, Z., Kadenczki, O., Gelley, A., Palatka, K., Papp, M., Zaránd, A., Lakatos, P., Veres, G., Fábián, A., Bálint, A., Bor, R., Szepes, Z., Farkas, K.: IBD-related malignancies and mortalities observed between 2015-2016-two years' results from the prospective nationwide hungarian registry.
    United European Gastroenterol J. 5 (5), A723, 2017.
  2. Gönczi, L., Gecse, K., Végh, Z., Kürti, Z., Rutka, M., Farkas, K., Golovics, P., Lovász, B., Banai, J., Bene, L., Gasztonyi, B., Kristóf, T., Lakatos, L., Miheller, P., Nagy, F., Palatka, K., Papp, M., Patai, Á., Salamon, Á., Szamosi, T., Szepes, Z., Tóth, G., Vincze, Á., Szalay, B., Molnár, T., Lakatos, P.: Long term efficacy, safety and immunogenicity of biosimilar infliximab after one year in a prospective nationwide cohort.
    Inflamm. Bowel Dis. 23 (11), 1908-1915, 2017.
    Journal metrics:
    D1 Gastroenterology
    Q1 Immunology and Allergy
  3. Gönczi, L., Végh, Z., Golovics, P., Rutka, M., Gecse, K., Bor, R., Farkas, K., Szamosi, T., Bene, L., Gasztonyi, B., Kristóf, T., Lakatos, L., Miheller, P., Palatka, K., Papp, M., Patai, Á., Salamon, Á., Tóth, G., Vincze, Á., Bíró, E., Lovász, B., Kürti, Z., Szepes, Z., Molnár, T., Lakatos, P.: Prediction of short- and medium-term efficacy of biosimilar infliximab therapy. Do trough levels/antidrug antibody levels or clinical/biochemical markers play a more important role?.
    J. Crohns Colitis. 11 (6), 697-705, 2017.
    Journal metrics:
    D1 Gastroenterology
    D1 Medicine (miscellaneous)
2016
  1. Gecse, K., Lovász, B., Farkas, K., Banai, J., Bene, L., Gasztonyi, B., Golovics, P., Kristóf, T., Lakatos, L., Csontos, Á., Juhász, M., Nagy, F., Palatka, K., Papp, M., Patai, Á., Lakner, L., Salamon, Á., Szamosi, T., Szepes, Z., Tóth, G., Vincze, Á., Szalay, B., Molnár, T., Lakatos, P.: Efficacy And Safety Of The Biosimilar Infliximab CT-P13 Treatment In Inflammatory Bowel Diseases: a Prospective, Multicentre, Nationwide Cohort.
    J. Crohns Colitis. 10 (2), 133-140, 2016.
    Journal metrics:
    D1 Gastroenterology
    D1 Medicine (miscellaneous)
2015
  1. Váradi, C., Holló, Z., Póliska, S., Nagy, L., Szekanecz, Z., Váncsa, A., Palatka, K., Guttman, A.: Combination of IgG N-glycomics and corresponding transcriptomics data to identify anti-TNFα treatment responders in inflammatory diseases.
    Electrophoresis. 36 (11-12), 1330-1335, 2015.
    Journal metrics:
    Q2 Analytical Chemistry
    Q2 Biochemistry
    Q2 Clinical Biochemistry
Show all
updated: 2024-04-14, 01:43

SCImago quartiles of
scientific journal articles

Number of scientific articles: 71
Q1/D1 14 (19.7%)
Q1 30 (42.3%)
Q2 9 (12.7%)
Q3 8 (11.3%)
Q4 4 (5.6%)
N/A 20 (28.2%)
-
OK

SCImago subject areas and categories

Medicine (48)
Medicine (miscellaneous) (25)
Gastroenterology (21)
Immunology and Allergy (10)
Hepatology (4)
Genetics (clinical) (2)
Pharmacology (medical) (2)
Dermatology (1)
Endocrinology, Diabetes and Metabolism (1)
Health Policy (1)
Microbiology (medical) (1)
Oncology (1)
Public Health, Environmental and Occupational Health (1)
Surgery (1)
Biochemistry, Genetics and Molecular Biology (9)
Clinical Biochemistry (4)
Biochemistry (2)
Genetics (2)
Endocrinology (1)
Molecular Biology (1)
Molecular Medicine (1)
Physiology (1)
Immunology and Microbiology (4)
Immunology (4)
Pharmacology, Toxicology and Pharmaceutics (3)
Pharmacology (3)
Drug Discovery (2)
Chemistry (1)
Analytical Chemistry (1)
Economics, Econometrics and Finance (1)
Economics, Econometrics and Finance (miscellaneous) (1)
Neuroscience (1)
Cellular and Molecular Neuroscience (1)

Genre chart

Year chart

Language chart

Journals

Show more

iDEa co-authors

Show more

Other co-authors

Show more
Lovász Barbara Dorottya
Élthes Zsuzsa Bianka
Juhász Márk Félix
Kocsis Katalin Ágnes
Kucserik Levente Pál
Neoptoleomos, Johan P.
Stalmeier, Peep F. M.
Udvardy Miklós László
Zouboulis, Christos C.